Maĭdannik V G
Vrach Delo. 1989 May(5):75-7.
Immunoenzymatic assay (IEA) was used to study the content of fibrinogen and its splitting products (FSP) in patients with pyelonephritis and glomerulonephritis. The active phase of the disease was characterized by a marked increase of the fibrinogen content and FSP in the blood. The changes reflect the process of activation of the blood coagulation system with hypercoagulation phenomena. Immunoenzymatic assay is perspective for the evaluation of the state of hemostasis in renal diseases and for controlling treatment efficacy.
采用免疫酶联分析法（IEA）研究肾盂肾炎和肾小球肾炎患者纤维蛋白原及其裂解产物（FSP）的含量。疾病活动期的特点是血液中纤维蛋白原含量和FSP显著增加。这些变化反映了凝血系统激活伴有高凝现象的过程。免疫酶联分析法对于评估肾脏疾病的止血状态和控制治疗效果具有重要意义。
